Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
Background Few studies have examined effectiveness of COVID-19 vaccines against
COVID-19 and all-cause mortality across different pandemic periods in 2022. Methods We …
COVID-19 and all-cause mortality across different pandemic periods in 2022. Methods We …
Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
IL Ward, C Robertson, U Agrawal, L Patterson… - Nature …, 2024 - nature.com
The emergence of the COVID-19 vaccination has been critical in changing the course of the
COVID-19 pandemic. To ensure protection remains high in vulnerable groups booster …
COVID-19 pandemic. To ensure protection remains high in vulnerable groups booster …
COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2 m population data-linkage cohort approach
M Perry, MB Gravenor, S Cottrell… - Human vaccines & …, 2022 - Taylor & Francis
Vaccination programs against COVID-19 vary globally with estimates of vaccine
effectiveness (VE) affected by vaccine type, schedule, strain, outcome, and recipient …
effectiveness (VE) affected by vaccine type, schedule, strain, outcome, and recipient …
[HTML][HTML] COVID-19 mortality and progress toward vaccinating older adults—World Health Organization, worldwide, 2020–2022
MK Wong - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
COVID-19 vaccines are safe and reduce COVID-19 mortality. The World Health
Organization (WHO) recommends that countries prioritize populations at increased risk, eg …
Organization (WHO) recommends that countries prioritize populations at increased risk, eg …
Importance of COVID-19 vaccine efficacy in older age groups
Importance An effective vaccine against SARS-CoV-2 will reduce morbidity and mortality
and allow substantial relaxation of physical distancing policies. However, the ability of a …
and allow substantial relaxation of physical distancing policies. However, the ability of a …
Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020–17 May 2021): a population-level …
E Tessier, Y Rai, E Clarke, A Lakhani, C Tsang… - BMJ open, 2022 - bmjopen.bmj.com
Objective To determine characteristics associated with COVID-19 vaccine coverage among
individuals aged 50 years and above in England since the beginning of the programme …
individuals aged 50 years and above in England since the beginning of the programme …
Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population cohort study
P Nordström, M Ballin, A Nordström - Hospitalization, and Death …, 2021 - papers.ssrn.com
Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19)
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
lasts longer than 6 months is unclear. Methods: A retrospective cohort study was conducted …
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the …
Background COVID-19 has been shown to differently affect various demographic and
clinical population subgroups. We aimed to describe trends in absolute and relative COVID …
clinical population subgroups. We aimed to describe trends in absolute and relative COVID …
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
B de Gier, L van Asten, TM Boere, A van Roon… - Vaccine, 2023 - Elsevier
Background We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality,
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million …
S Bedston, F Almaghrabi, L Patterson… - The Lancet Regional …, 2024 - thelancet.com
Background UK COVID-19 vaccination policy has evolved to offering COVID-19 booster
doses to individuals at increased risk of severe Illness from COVID-19. Building on our …
doses to individuals at increased risk of severe Illness from COVID-19. Building on our …